American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$374M |
| 2 |
Meta Platforms (Facebook)
META
|
+$255M |
| 3 |
Salesforce
CRM
|
+$200M |
| 4 |
Target
TGT
|
+$132M |
| 5 |
Reinsurance Group of America
RGA
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$322M |
| 2 |
Visa
V
|
+$240M |
| 3 |
T-Mobile US
TMUS
|
+$229M |
| 4 |
MSCI
MSCI
|
+$209M |
| 5 |
IQVIA
IQV
|
+$209M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Healthcare | 13.84% |
| 3 | Financials | 13.35% |
| 4 | Consumer Discretionary | 11.5% |
| 5 | Industrials | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Kiniksa Pharmaceuticals
KNSA
$6.07B
| $158K | ﹤0.01% |
+11,205
| New | +$150K |
|
|
ROVR
2552
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $155K | ﹤0.01% |
31,582
+3,202
| +11% | +$14.6K |
|
|
BLFY
2553
DELISTED
Blue Foundry Bancorp
BLFY
| $153K | ﹤0.01% |
+15,098
| New | +$146K |
|
2554
Adtran
ADTN
$665M
| $152K | ﹤0.01% |
+14,450
| New | +$143K |
|
2555
Lifecore Biomedical
LFCR
$180M
| $151K | ﹤0.01% |
+15,578
| New | +$95.1K |
|
2556
Butterfly Network
BFLY
$2.47B
| $150K | ﹤0.01% |
65,033
+27,508
| +73% | +$61.5K |
|
2557
McEwen Inc
MUX
$1.13B
| $148K | ﹤0.01% |
+20,622
| New | +$166K |
|
|
KALV
2558
DELISTED
KalVista Pharmaceuticals
KALV
| $148K | ﹤0.01% |
+16,446
| New | +$152K |
|
2559
Oric Pharmaceuticals
ORIC
$1.44B
| $147K | ﹤0.01% |
+18,959
| New | +$108K |
|
|
NXDR
2560
Nextdoor Holdings
NXDR
$998M
| $147K | ﹤0.01% |
45,003
+32,058
| +248% | +$79.5K |
|
2561
PetMed Express
PETS
$42.1M
| $146K | ﹤0.01% |
+10,596
| New | +$159K |
|
2562
Zegna
ZGN
$3.74B
| $145K | ﹤0.01% |
+11,422
| New | +$142K |
|
2563
3D Systems Corp
DDD
$601M
| $143K | ﹤0.01% |
+14,384
| New | +$132K |
|
2564
TaskUs
TASK
$650M
| $140K | ﹤0.01% |
+12,326
| New | +$150K |
|
|
SHCR
2565
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $139K | ﹤0.01% |
79,279
| – | – |
|
2566
AngioDynamics
ANGO
$641M
| $138K | ﹤0.01% |
+13,270
| New | +$128K |
|
2567
SiriusXM
SIRI
$9.42B
| $137K | ﹤0.01% |
3,015
+26
| +0.9% | +$982 |
|
|
SBT
2568
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $136K | ﹤0.01% |
24,862
-2,554
| -9% | -$13.4K |
|
|
API
2569
Agora
API
$401M
| $136K | ﹤0.01% |
43,313
| – | – |
|
|
RPTX
2570
DELISTED
Repare Therapeutics
RPTX
| $135K | ﹤0.01% |
+12,730
| New | +$131K |
|
2571
Chegg
CHGG
$86.3M
| $134K | ﹤0.01% |
15,061
-10,907
| -42% | -$132K |
|
|
FPI
2572
Farmland Partners
FPI
$425M
| $133K | ﹤0.01% |
10,927
+844
| +8% | +$9.45K |
|
|
SFIX
2573
Stitch Fix
SFIX
$484M
| $133K | ﹤0.01% |
34,512
+23,584
| +216% | +$89.3K |
|
2574
Sutro Biopharma
STRO
$358M
| $133K | ﹤0.01% |
2,851
+1,385
| +94% | +$68.9K |
|
2575
Liberty Latin America Class A
LILA
$1.67B
| $131K | ﹤0.01% |
+22,089
| New | +$124K |
|
Similar funds
American Century Companies's Q2 2023 Portfolio in Review
As of Q2 2023, American Century Companies held 2,884 positions worth $133B, up 4.5% from $127B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
American Century Companies's Q2 2023 filing shows 216 new, 1,601 increased, 807 reduced and 96 closed positions. Its largest new stake was Kenvue: 2,518,495 shares worth $66.5M. The largest sale was Microsoft, an estimated $322M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- American Century Companies's largest Q2 2023 buy was Kenvue: 2,518,495 shares worth $66.5M.
- American Century Companies added most to Becton Dickinson in Q2 2023, an estimated $374M increase.
- American Century Companies's biggest Q2 2023 reduction was Microsoft, cutting an estimated $322M.
- American Century Companies fully exited Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B in Q2 2023, selling an estimated $199M.
- American Century Companies's ten largest holdings make up 22% of its $133B portfolio in Q2 2023.
- American Century Companies opened 216 new positions and closed 96 in Q2 2023.
- American Century Companies's portfolio value rose 4.5% quarter-over-quarter to $133B.
Based on American Century Companies's 13F filing for Q2 2023, filed 14 Aug 2023.